Skip to main content
Funded Studies

David Vocadlo, PhD

Professor and Canada Research Chair in Chemical Biology at Simon Fraser University

Location: Burnaby BC Canada

David Vocadlo completed his PhD at the University of British Columbia in 2002. He was a postdoctoral fellow in the department of chemistry at the University of California at Berkeley. In 2004, he moved to Simon Fraser University (SFU), where he is now professor of chemistry and of molecular biology and biochemistry, co-director of the Center for High-Throughput Chemical Biology and Tier I Canada Research Chair in chemical biology. His research focuses on developing chemical biology tools to advance understanding the roles of glycoconjugates in health and disease. Dr. Vocadlo pioneered the creation and preclinical validation of glycosylation inhibitors for neurodegenerative diseases, a strategy now advanced into clinic trials. His research has been recognized with various awards including the EWR Steacie Memorial Fellowship, the Horace Isbell Award of the American Chemical Society and appointment as an inaugural member of the Royal Society of Canada, College of New Scholars.

Associated Grants

  • Implementation and Validation of Lysosome-specific Tests of GCase Activity in Cell Lines and Human Peripheral Blood


  • Identifying Genes that Enhance the Activity of Glucocerebrosidase


  • Developing an Assay to Identify Glucocerebrosidase-enhancing Chaperones for the Treatment of Parkinson’s Disease


  • Live Cell Image-based Screening and Validation of Glucocerebrosidase Activators


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.